APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glucosamine and Chondroitin Sulfate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucosamine and Chondroitin Sulfate Industry Growth and Trends Forecast to 2032

Report ID 173995540120 December 2025128 pages

Choose your research edition.

Industry ResearchGlucosamine and Chondroitin Sulfate Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucosamine and Chondroitin Sulfate Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Glucosamine and Chondroitin Sulfate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucosamine and Chondroitin Sulfate Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucosamine and Chondroitin Sulfate Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Glucosamine and Chondroitin Sulfate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucosamine and Chondroitin Sulfate include ANXIN, Yantai Dongcheng, Runxin Biotechnology, WanTuMing Biological, Hengjie Bio-Pharmaceuticals, YBCC, TSI Group, Summit Nutritionals International and Summit Nutritionals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucosamine and Chondroitin Sulfate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucosamine and Chondroitin Sulfate market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucosamine and Chondroitin Sulfate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucosamine and Chondroitin Sulfate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucosamine and Chondroitin Sulfate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucosamine and Chondroitin Sulfate Market by Company

ANXIN

Yantai Dongcheng

Runxin Biotechnology

WanTuMing Biological

Hengjie Bio-Pharmaceuticals

YBCC

TSI Group

Summit Nutritionals International

Summit Nutritionals

Sioux Pharm

Ruikangda Biochemical

QJBCHINA

Pacific Rainbow

Nippon Zoki

Meitek (Synutra International)

ISBA

Huiwen

Guanglong Biochem

GGI

Focus Chem

Glucosamine and Chondroitin Sulfate Segment by Type

Food Grade Glucosamine and Chondroitin Sulfate

Pharmaceutical Grade Glucosamine and Chondroitin Sulfate

Glucosamine and Chondroitin Sulfate Segment by Application

Cosmetics

Dietary Supplements

Pharmaceutical

Others

Glucosamine and Chondroitin Sulfate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosamine and Chondroitin Sulfate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucosamine and Chondroitin Sulfate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosamine and Chondroitin Sulfate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucosamine and Chondroitin Sulfate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucosamine and Chondroitin Sulfate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Food Grade Glucosamine and Chondroitin Sulfate Table 2. Major Company of Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Table 3. Global Glucosamine and Chondroitin Sulfate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 5. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type (2021-2026) Table 8. Global Glucosamine and Chondroitin Sulfate Price by Type (2021-2026) & (US$/unit) Table 9. Global Glucosamine and Chondroitin Sulfate Sales by Type (2027-2032) & (k units) Table 10. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Glucosamine and Chondroitin Sulfate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type (2027-2032) Table 13. Global Glucosamine and Chondroitin Sulfate Price by Type (2027-2032) & (US$/unit) Table 14. North America Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 15. North America Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 17. Europe Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 21. Latin America Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Type (2021-2026) & (US$ Million) Table 24. Glucosamine and Chondroitin Sulfate Industry Trends Table 25. Glucosamine and Chondroitin Sulfate Industry Drivers Table 26. Glucosamine and Chondroitin Sulfate Industry Opportunities and Challenges Table 27. Glucosamine and Chondroitin Sulfate Industry Restraints Table 28. Global Glucosamine and Chondroitin Sulfate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Glucosamine and Chondroitin Sulfate Revenue Market Share by Company (2021-2026) Table 30. Global Glucosamine and Chondroitin Sulfate Sales by Company (2021-2026) & (k units) Table 31. Global Glucosamine and Chondroitin Sulfate Sales Share by Company (2021-2026) Table 32. Global Glucosamine and Chondroitin Sulfate Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Glucosamine and Chondroitin Sulfate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glucosamine and Chondroitin Sulfate Major Company Production Sites and Headquarters Table 35. Global Glucosamine and Chondroitin Sulfate Company, Product Type & Application Table 36. Global Glucosamine and Chondroitin Sulfate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Glucosamine and Chondroitin Sulfate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glucosamine and Chondroitin Sulfate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Glucosamine and Chondroitin Sulfate Sales by Region (2021-2026) & (k units) Table 41. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Glucosamine and Chondroitin Sulfate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Region (2021-2026) Table 44. Global Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Glucosamine and Chondroitin Sulfate Sales by Region (2027-2032) & (k units) Table 46. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Glucosamine and Chondroitin Sulfate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Region (2027-2032) Table 49. Global Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Glucosamine and Chondroitin Sulfate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 52. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application (2021-2026) Table 55. Global Glucosamine and Chondroitin Sulfate Price by Application (2021-2026) & (US$/unit) Table 56. Global Glucosamine and Chondroitin Sulfate Sales by Application (2027-2032) & (k units) Table 57. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Glucosamine and Chondroitin Sulfate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application (2027-2032) Table 60. Global Glucosamine and Chondroitin Sulfate Price by Application (2027-2032) & (US$/unit) Table 61. North America Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 62. North America Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 64. Europe Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 68. Latin America Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Application (2021-2026) & (US$ Million) Table 71. ANXIN Company Information Table 72. ANXIN Business Overview Table 73. ANXIN Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. ANXIN Glucosamine and Chondroitin Sulfate Product Portfolio Table 75. ANXIN Recent Development Table 76. Yantai Dongcheng Company Information Table 77. Yantai Dongcheng Business Overview Table 78. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product Portfolio Table 80. Yantai Dongcheng Recent Development Table 81. Runxin Biotechnology Company Information Table 82. Runxin Biotechnology Business Overview Table 83. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product Portfolio Table 85. Runxin Biotechnology Recent Development Table 86. WanTuMing Biological Company Information Table 87. WanTuMing Biological Business Overview Table 88. WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. WanTuMing Biological Glucosamine and Chondroitin Sulfate Product Portfolio Table 90. WanTuMing Biological Recent Development Table 91. Hengjie Bio-Pharmaceuticals Company Information Table 92. Hengjie Bio-Pharmaceuticals Business Overview Table 93. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product Portfolio Table 95. Hengjie Bio-Pharmaceuticals Recent Development Table 96. YBCC Company Information Table 97. YBCC Business Overview Table 98. YBCC Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. YBCC Glucosamine and Chondroitin Sulfate Product Portfolio Table 100. YBCC Recent Development Table 101. TSI Group Company Information Table 102. TSI Group Business Overview Table 103. TSI Group Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. TSI Group Glucosamine and Chondroitin Sulfate Product Portfolio Table 105. TSI Group Recent Development Table 106. Summit Nutritionals International Company Information Table 107. Summit Nutritionals International Business Overview Table 108. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product Portfolio Table 110. Summit Nutritionals International Recent Development Table 111. Summit Nutritionals Company Information Table 112. Summit Nutritionals Business Overview Table 113. Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Summit Nutritionals Glucosamine and Chondroitin Sulfate Product Portfolio Table 115. Summit Nutritionals Recent Development Table 116. Sioux Pharm Company Information Table 117. Sioux Pharm Business Overview Table 118. Sioux Pharm Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Sioux Pharm Glucosamine and Chondroitin Sulfate Product Portfolio Table 120. Sioux Pharm Recent Development Table 121. Ruikangda Biochemical Company Information Table 122. Ruikangda Biochemical Business Overview Table 123. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product Portfolio Table 125. Ruikangda Biochemical Recent Development Table 126. QJBCHINA Company Information Table 127. QJBCHINA Business Overview Table 128. QJBCHINA Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. QJBCHINA Glucosamine and Chondroitin Sulfate Product Portfolio Table 130. QJBCHINA Recent Development Table 131. Pacific Rainbow Company Information Table 132. Pacific Rainbow Business Overview Table 133. Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Pacific Rainbow Glucosamine and Chondroitin Sulfate Product Portfolio Table 135. Pacific Rainbow Recent Development Table 136. Nippon Zoki Company Information Table 137. Nippon Zoki Business Overview Table 138. Nippon Zoki Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Nippon Zoki Glucosamine and Chondroitin Sulfate Product Portfolio Table 140. Nippon Zoki Recent Development Table 141. Meitek (Synutra International) Company Information Table 142. Meitek (Synutra International) Business Overview Table 143. Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Product Portfolio Table 145. Meitek (Synutra International) Recent Development Table 146. ISBA Company Information Table 147. ISBA Business Overview Table 148. ISBA Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. ISBA Glucosamine and Chondroitin Sulfate Product Portfolio Table 150. ISBA Recent Development Table 151. Huiwen Company Information Table 152. Huiwen Business Overview Table 153. Huiwen Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Huiwen Glucosamine and Chondroitin Sulfate Product Portfolio Table 155. Huiwen Recent Development Table 156. Guanglong Biochem Company Information Table 157. Guanglong Biochem Business Overview Table 158. Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Guanglong Biochem Glucosamine and Chondroitin Sulfate Product Portfolio Table 160. Guanglong Biochem Recent Development Table 161. GGI Company Information Table 162. GGI Business Overview Table 163. GGI Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. GGI Glucosamine and Chondroitin Sulfate Product Portfolio Table 165. GGI Recent Development Table 166. Focus Chem Company Information Table 167. Focus Chem Business Overview Table 168. Focus Chem Glucosamine and Chondroitin Sulfate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Focus Chem Glucosamine and Chondroitin Sulfate Product Portfolio Table 170. Focus Chem Recent Development Table 171. North America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. North America Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 173. North America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 174. North America Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032) & (k units) Table 175. North America Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Country (2027-2032) Table 176. North America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Glucosamine and Chondroitin Sulfate Market Share by Country (2021-2026) Table 179. North America Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Glucosamine and Chondroitin Sulfate Market Share Forecast by Country (2027-2032) Table 181. Europe Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Europe Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 183. Europe Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 184. Europe Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032) & (k units) Table 185. Europe Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Glucosamine and Chondroitin Sulfate Market Share by Country (2021-2026) Table 189. Europe Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Glucosamine and Chondroitin Sulfate Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 193. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032) & (k units) Table 195. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Share by Country (2021-2026) Table 199. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Share Forecast by Country (2027-2032) Table 201. Latin America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Latin America Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 203. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 204. Latin America Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032) & (k units) Table 205. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Glucosamine and Chondroitin Sulfate Market Share by Country (2021-2026) Table 209. Latin America Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Glucosamine and Chondroitin Sulfate Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 213. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032) & (k units) Table 215. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Share by Country (2021-2026) Table 219. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Glucosamine and Chondroitin Sulfate Distributors List Table 224. Glucosamine and Chondroitin Sulfate Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Glucosamine and Chondroitin Sulfate Image Figure 2. Global Glucosamine and Chondroitin Sulfate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucosamine and Chondroitin Sulfate Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucosamine and Chondroitin Sulfate Sales (2021-2032) & (k units) Figure 5. Food Grade Glucosamine and Chondroitin Sulfate Image Figure 6. Global Food Grade Glucosamine and Chondroitin Sulfate Sales YoY Growth (2021-2032) & (k units) Figure 7. Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Image Figure 8. Global Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Glucosamine and Chondroitin Sulfate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Glucosamine and Chondroitin Sulfate Market Share by Type 2025 VS 2032 Figure 11. North America Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type in 2025 Figure 12. North America Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type in 2025 Figure 13. Europe Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Glucosamine and Chondroitin Sulfate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cosmetics Image Figure 24. Global Cosmetics Sales YoY Growth (2021-2032) & (k units) Figure 25. Dietary Supplements Image Figure 26. Global Dietary Supplements Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmaceutical Image Figure 28. Global Pharmaceutical Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Glucosamine and Chondroitin Sulfate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Glucosamine and Chondroitin Sulfate Market Share by Application 2025 VS 2032 Figure 33. North America Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application in 2025 Figure 34. North America Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application in 2025 Figure 35. Europe Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application in 2025 Figure 36. Europe Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application in 2025 Figure 39. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share in Value by Application in 2025 Figure 43. North America Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Glucosamine and Chondroitin Sulfate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Glucosamine and Chondroitin Sulfate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Glucosamine and Chondroitin Sulfate Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Glucosamine and Chondroitin Sulfate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Glucosamine and Chondroitin Sulfate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Glucosamine and Chondroitin Sulfate Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Glucosamine and Chondroitin Sulfate Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Glucosamine and Chondroitin Sulfate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Glucosamine and Chondroitin Sulfate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Glucosamine and Chondroitin Sulfate Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Glucosamine and Chondroitin Sulfate Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Glucosamine and Chondroitin Sulfate Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Glucosamine and Chondroitin Sulfate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade Glucosamine and Chondroitin Sulfate
  • Pharmaceutical Grade Glucosamine and Chondroitin Sulfate
Applications
  • Cosmetics
  • Dietary Supplements
  • Pharmaceutical
  • Others
Companies covered
  • ANXIN
  • Yantai Dongcheng
  • Runxin Biotechnology
  • WanTuMing Biological
  • Hengjie Bio-Pharmaceuticals
  • YBCC
  • TSI Group
  • Summit Nutritionals International
  • Summit Nutritionals
  • Sioux Pharm
  • Ruikangda Biochemical
  • QJBCHINA
  • Pacific Rainbow
  • Nippon Zoki
  • Meitek (Synutra International)
  • ISBA
  • Huiwen
  • Guanglong Biochem
  • GGI
  • Focus Chem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucosamine and Chondroitin Sulfate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucosamine and Chondroitin Sulfate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucosamine and Chondroitin Sulfate Market by Type
  6. 1.3.1 Food Grade Glucosamine and Chondroitin Sulfate
  7. 1.3.2 Pharmaceutical Grade Glucosamine and Chondroitin Sulfate
  8. 1.4 Global Glucosamine and Chondroitin Sulfate Market Size by Type
  9. 1.4.1 Global Glucosamine and Chondroitin Sulfate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Glucosamine and Chondroitin Sulfate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Glucosamine and Chondroitin Sulfate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Glucosamine and Chondroitin Sulfate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Glucosamine and Chondroitin Sulfate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Glucosamine and Chondroitin Sulfate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucosamine and Chondroitin Sulfate Industry Trends
  2. 2.2 Glucosamine and Chondroitin Sulfate Industry Drivers
  3. 2.3 Glucosamine and Chondroitin Sulfate Industry Opportunities and Challenges
  4. 2.4 Glucosamine and Chondroitin Sulfate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucosamine and Chondroitin Sulfate Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucosamine and Chondroitin Sulfate Sales (2021-2026)
  3. 3.3 Global Top Players by Glucosamine and Chondroitin Sulfate Price (2021-2026)
  4. 3.4 Global Glucosamine and Chondroitin Sulfate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucosamine and Chondroitin Sulfate Major Company Production Sites & Headquarters
  6. 3.6 Global Glucosamine and Chondroitin Sulfate Company, Product Type & Application
  7. 3.7 Global Glucosamine and Chondroitin Sulfate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucosamine and Chondroitin Sulfate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucosamine and Chondroitin Sulfate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucosamine and Chondroitin Sulfate Tier 1, Tier 2, and Tier 3
4 Glucosamine and Chondroitin Sulfate Regional Status and Outlook
  1. 4.1 Global Glucosamine and Chondroitin Sulfate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucosamine and Chondroitin Sulfate Historic Market Size by Region
  3. 4.2.1 Global Glucosamine and Chondroitin Sulfate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucosamine and Chondroitin Sulfate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucosamine and Chondroitin Sulfate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucosamine and Chondroitin Sulfate Forecasted Market Size by Region
  7. 4.3.1 Global Glucosamine and Chondroitin Sulfate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucosamine and Chondroitin Sulfate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucosamine and Chondroitin Sulfate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucosamine and Chondroitin Sulfate by Application
  1. 5.1 Glucosamine and Chondroitin Sulfate Market by Application
  2. 5.1.1 Cosmetics
  3. 5.1.2 Dietary Supplements
  4. 5.1.3 Pharmaceutical
  5. 5.1.4 Others
  6. 5.2 Global Glucosamine and Chondroitin Sulfate Market Size by Application
  7. 5.2.1 Global Glucosamine and Chondroitin Sulfate Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Glucosamine and Chondroitin Sulfate Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Glucosamine and Chondroitin Sulfate Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Glucosamine and Chondroitin Sulfate Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Glucosamine and Chondroitin Sulfate Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Glucosamine and Chondroitin Sulfate Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ANXIN
  2. 6.1.1 ANXIN Company Information
  3. 6.1.2 ANXIN Business Overview
  4. 6.1.3 ANXIN Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ANXIN Glucosamine and Chondroitin Sulfate Product Portfolio
  6. 6.1.5 ANXIN Recent Developments
  7. 6.2 Yantai Dongcheng
  8. 6.2.1 Yantai Dongcheng Company Information
  9. 6.2.2 Yantai Dongcheng Business Overview
  10. 6.2.3 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product Portfolio
  12. 6.2.5 Yantai Dongcheng Recent Developments
  13. 6.3 Runxin Biotechnology
  14. 6.3.1 Runxin Biotechnology Company Information
  15. 6.3.2 Runxin Biotechnology Business Overview
  16. 6.3.3 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product Portfolio
  18. 6.3.5 Runxin Biotechnology Recent Developments
  19. 6.4 WanTuMing Biological
  20. 6.4.1 WanTuMing Biological Company Information
  21. 6.4.2 WanTuMing Biological Business Overview
  22. 6.4.3 WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 WanTuMing Biological Glucosamine and Chondroitin Sulfate Product Portfolio
  24. 6.4.5 WanTuMing Biological Recent Developments
  25. 6.5 Hengjie Bio-Pharmaceuticals
  26. 6.5.1 Hengjie Bio-Pharmaceuticals Company Information
  27. 6.5.2 Hengjie Bio-Pharmaceuticals Business Overview
  28. 6.5.3 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product Portfolio
  30. 6.5.5 Hengjie Bio-Pharmaceuticals Recent Developments
  31. 6.6 YBCC
  32. 6.6.1 YBCC Company Information
  33. 6.6.2 YBCC Business Overview
  34. 6.6.3 YBCC Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 YBCC Glucosamine and Chondroitin Sulfate Product Portfolio
  36. 6.6.5 YBCC Recent Developments
  37. 6.7 TSI Group
  38. 6.7.1 TSI Group Company Information
  39. 6.7.2 TSI Group Business Overview
  40. 6.7.3 TSI Group Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 TSI Group Glucosamine and Chondroitin Sulfate Product Portfolio
  42. 6.7.5 TSI Group Recent Developments
  43. 6.8 Summit Nutritionals International
  44. 6.8.1 Summit Nutritionals International Company Information
  45. 6.8.2 Summit Nutritionals International Business Overview
  46. 6.8.3 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product Portfolio
  48. 6.8.5 Summit Nutritionals International Recent Developments
  49. 6.9 Summit Nutritionals
  50. 6.9.1 Summit Nutritionals Company Information
  51. 6.9.2 Summit Nutritionals Business Overview
  52. 6.9.3 Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Summit Nutritionals Glucosamine and Chondroitin Sulfate Product Portfolio
  54. 6.9.5 Summit Nutritionals Recent Developments
  55. 6.10 Sioux Pharm
  56. 6.10.1 Sioux Pharm Company Information
  57. 6.10.2 Sioux Pharm Business Overview
  58. 6.10.3 Sioux Pharm Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sioux Pharm Glucosamine and Chondroitin Sulfate Product Portfolio
  60. 6.10.5 Sioux Pharm Recent Developments
  61. 6.11 Ruikangda Biochemical
  62. 6.11.1 Ruikangda Biochemical Company Information
  63. 6.11.2 Ruikangda Biochemical Business Overview
  64. 6.11.3 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product Portfolio
  66. 6.11.5 Ruikangda Biochemical Recent Developments
  67. 6.12 QJBCHINA
  68. 6.12.1 QJBCHINA Company Information
  69. 6.12.2 QJBCHINA Business Overview
  70. 6.12.3 QJBCHINA Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 QJBCHINA Glucosamine and Chondroitin Sulfate Product Portfolio
  72. 6.12.5 QJBCHINA Recent Developments
  73. 6.13 Pacific Rainbow
  74. 6.13.1 Pacific Rainbow Company Information
  75. 6.13.2 Pacific Rainbow Business Overview
  76. 6.13.3 Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pacific Rainbow Glucosamine and Chondroitin Sulfate Product Portfolio
  78. 6.13.5 Pacific Rainbow Recent Developments
  79. 6.14 Nippon Zoki
  80. 6.14.1 Nippon Zoki Company Information
  81. 6.14.2 Nippon Zoki Business Overview
  82. 6.14.3 Nippon Zoki Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Nippon Zoki Glucosamine and Chondroitin Sulfate Product Portfolio
  84. 6.14.5 Nippon Zoki Recent Developments
  85. 6.15 Meitek (Synutra International)
  86. 6.15.1 Meitek (Synutra International) Company Information
  87. 6.15.2 Meitek (Synutra International) Business Overview
  88. 6.15.3 Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Product Portfolio
  90. 6.15.5 Meitek (Synutra International) Recent Developments
  91. 6.16 ISBA
  92. 6.16.1 ISBA Company Information
  93. 6.16.2 ISBA Business Overview
  94. 6.16.3 ISBA Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 ISBA Glucosamine and Chondroitin Sulfate Product Portfolio
  96. 6.16.5 ISBA Recent Developments
  97. 6.17 Huiwen
  98. 6.17.1 Huiwen Company Information
  99. 6.17.2 Huiwen Business Overview
  100. 6.17.3 Huiwen Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Huiwen Glucosamine and Chondroitin Sulfate Product Portfolio
  102. 6.17.5 Huiwen Recent Developments
  103. 6.18 Guanglong Biochem
  104. 6.18.1 Guanglong Biochem Company Information
  105. 6.18.2 Guanglong Biochem Business Overview
  106. 6.18.3 Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Guanglong Biochem Glucosamine and Chondroitin Sulfate Product Portfolio
  108. 6.18.5 Guanglong Biochem Recent Developments
  109. 6.19 GGI
  110. 6.19.1 GGI Company Information
  111. 6.19.2 GGI Business Overview
  112. 6.19.3 GGI Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 GGI Glucosamine and Chondroitin Sulfate Product Portfolio
  114. 6.19.5 GGI Recent Developments
  115. 6.20 Focus Chem
  116. 6.20.1 Focus Chem Company Information
  117. 6.20.2 Focus Chem Business Overview
  118. 6.20.3 Focus Chem Glucosamine and Chondroitin Sulfate Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Focus Chem Glucosamine and Chondroitin Sulfate Product Portfolio
  120. 6.20.5 Focus Chem Recent Developments
7 North America by Country
  1. 7.1 North America Glucosamine and Chondroitin Sulfate Sales by Country
  2. 7.1.1 North America Glucosamine and Chondroitin Sulfate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  4. 7.1.3 North America Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucosamine and Chondroitin Sulfate Market Size by Country
  6. 7.2.1 North America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucosamine and Chondroitin Sulfate Sales by Country
  2. 8.1.1 Europe Glucosamine and Chondroitin Sulfate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucosamine and Chondroitin Sulfate Market Size by Country
  6. 8.2.1 Europe Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Country
  2. 9.1.1 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size by Country
  6. 9.2.1 Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucosamine and Chondroitin Sulfate Sales by Country
  2. 10.1.1 South America Glucosamine and Chondroitin Sulfate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  4. 10.1.3 South America Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucosamine and Chondroitin Sulfate Market Size by Country
  6. 10.2.1 South America Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country
  2. 11.1.1 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size by Country
  6. 11.2.1 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucosamine and Chondroitin Sulfate Value Chain Analysis
  2. 12.1.1 Glucosamine and Chondroitin Sulfate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucosamine and Chondroitin Sulfate Production Mode & Process
  7. 12.2 Glucosamine and Chondroitin Sulfate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucosamine and Chondroitin Sulfate Distributors
  10. 12.2.3 Glucosamine and Chondroitin Sulfate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst